Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 14,460,000 | 14,462,000 | 12,310,000 | 14,301,000 | 13,927,000 |
| Cost of Goods | 4,212,000 | 4,202,000 | 4,094,000 | 5,704,000 | 6,485,000 |
| Gross Profit | 10,248,000 | 10,260,000 | 8,216,000 | 8,597,000 | 7,442,000 |
| Operating Expenses | 6,417,000 | 6,262,000 | 5,418,000 | 5,402,000 | 5,161,000 |
| Operating Income | 3,831,000 | 3,998,000 | 2,798,000 | 3,195,000 | 2,281,000 |
| Interest Expense | 591,000 | 506,000 | 453,000 | 378,000 | 398,000 |
| Other Income | -1,156,000 | -1,346,000 | -590,000 | -1,605,000 | 70,000 |
| Pre-tax Income | 2,084,000 | 2,146,000 | 1,755,000 | 1,212,000 | 1,953,000 |
| Income Tax | 520,000 | 773,000 | 383,000 | 388,000 | 172,000 |
| Net Income Continuous | 1,564,000 | 1,373,000 | 1,372,000 | 824,000 | 1,781,000 |
| Minority Interests | 3,000 | 3,000 | 3,000 | 2,000 | 3,000 |
| Net Income | $1,561,000 | $1,370,000 | $1,369,000 | $822,000 | $1,778,000 |
| EPS Basic Total Ops | 0.88 | 0.77 | 0.77 | 0.46 | 1.00 |
| EPS Basic Continuous Ops | 0.88 | 0.78 | 0.78 | 0.47 | 1.01 |
| EPS Diluted Total Ops | 0.88 | 0.77 | 0.77 | 0.45 | 1.00 |
| EPS Diluted Continuous Ops | 0.88 | 0.78 | 0.77 | 0.46 | 1.01 |
| EPS Diluted Before Non-Recurring Items | 3.00 | 2.65 | 2.31 | 2.79 | 2.95 |
| EBITDA(a) | $5,910,000 | $6,129,000 | $4,872,000 | $5,271,000 | $4,516,000 |